lab inv (2)

Embed Size (px)

Citation preview

  • 7/31/2019 lab inv (2)

    1/90

    Good morning

  • 7/31/2019 lab inv (2)

    2/90

    Lab investgations in

    oral and maxillofacial surgery

    Dr.ch.v.rao

  • 7/31/2019 lab inv (2)

    3/90

    Contents

    Hematology:-Estimation of haemoglobin-Total RBC count-Total & Differential WBC count

    -Blood group determination-Determination of Haematocrit-RBC indices-ESR

    -Absolute eosinophil and platlet count-BT/CT/PT/PTT/APTT-Blood banking techniques

  • 7/31/2019 lab inv (2)

    4/90

    Clinical microbiology- Various staining techniques

    - Culture media

    - Diagnostic serology

  • 7/31/2019 lab inv (2)

    5/90

    Clinical chemistry:

    - Organ function tests

    - Determination of serum bilirubin

    - Thyroid function test

    - Tests for diabetes

    - Total serum protein estimation

  • 7/31/2019 lab inv (2)

    6/90

    Routine examination of body

    fluids and faeces

    - Routine examination of urine

    - Routine examination of feces- Examination of sputum

    - Examination of cavity fluids

  • 7/31/2019 lab inv (2)

    7/90

    EFFECTIVE DIAGNOSIS HAS 4 ESSENTIAL

    REQUISITES

    1.Awareness of pattern of clinical presentation

    2.Obtaining a complete history3.Undertaking a systematic clinical examination

    4.Formulating an appropriate investigative plan

  • 7/31/2019 lab inv (2)

    8/90

    Clinical symptoms of some diseases are

    non specific, underlying conditions maynot be suspected from the history aloneand at times the physical examination

    may be surprisingly unrevealing

    Its often the routine investigations thatsuggest the presence of underlying

    pathology.

  • 7/31/2019 lab inv (2)

    9/90

    NATURE OF WORK :

    Four major areas in most clinical laboratories.

    Hematology

    Clinical microbiology

    Clinical chemistry

    Routine examination of body fluids andfaeces

  • 7/31/2019 lab inv (2)

    10/90

    Purpose of diagnostic tests:

    Help to confirm a diagnosis Monitor an illness

    Provide valuable information about the clients

    response to treatment

  • 7/31/2019 lab inv (2)

    11/90

    Diagnostic testing involves three phases:-

    Pretest

    The major focus of the pretest phase is client

    preparation

    The nurse must know what equipment

    and supplies are needed for the

    specific test

    What type of sample will be needed

    and how it will be collected?

    Does the client need to stop oral

    intake for a certain number of hours

    prior to the test?

  • 7/31/2019 lab inv (2)

    12/90

    Does the test include administration of

    contrast media and if so, it is injected

    or swallowed?

    Are medications given or withheld?

    Is consent form required?

    How long is the test?

  • 7/31/2019 lab inv (2)

    13/90

    Intratest

    It focuses on specimen collection and

    performing or assisting with certain diagnostic

    testing.

    The nurses uses of special standard

    precautions and sterile techniques

    Provide emotional and physical support while

    monitoring the client as needed (e.g., V /S,

    pulse oximetry, ECG). Correct labeling, storage, and transportation of

    the specimen to avoid invalid test results.

  • 7/31/2019 lab inv (2)

    14/90

    Post test

    The focus of this phase is on nursing care of theclient and follow up activities and

    observations.

    Compare the previous and current test results

    Modify nursing interventions as needed

    Report the results to appropriate health team

    members.

  • 7/31/2019 lab inv (2)

    15/90

    According to STEINER

    The laboratory tests and profiles can be classified into three groups.

    Group 1 :Those that play an integral role in confirmingthe diagnosis of tissue changes confronted by the

    clinician.

    Group II : Those that bear directly on the managementof a patient during surgery

    Group III :Those that may have a bearing on overallhealth and management of patient.

  • 7/31/2019 lab inv (2)

    16/90

  • 7/31/2019 lab inv (2)

    17/90

    (Group II) tests

    1. Complete blood count

    2. Urine analysis

    3. Blood chemistry

    4. Determination of BT/CT/PT/PTT

  • 7/31/2019 lab inv (2)

    18/90

  • 7/31/2019 lab inv (2)

    19/90

    Estimation of heamoglobin

    Measured commonly to obtain informationabout circulating RBC and the amount

    Of oxygen carrying substance they contain

  • 7/31/2019 lab inv (2)

    20/90

    Sahlis method:Cynomethemoglobin method:

    Alkaline haematin method:

    Haldens carboxyhaemoglobin method:Oxyhaemoglobin method:

    Gasometric determation method

    Specific gravity method

    Photometric method

  • 7/31/2019 lab inv (2)

    21/90

    Principle ofSahlis method: When blood is added to 0.1N HCl, Hb is

    converted to brown colored acid hematin. The

    resulting color after dilution is compared withstandard brown glass reference of Sahli

    hemoglobinometer.

  • 7/31/2019 lab inv (2)

    22/90

    Principle of Cynomethemoglobin method:

    When blood is mixed with Drakins reagentcontaining Potassium Cyanide and Ferric

    cyanide, Hb reacts with Ferric cyanide to formmethemoglobin which is converted to stableCynomethemoglobin by the cyanide. Theintensity of color is proportional to Hb

    concentration and it is compared with a knownCynomethemoglobin standard at 540nm (greenfilter.)

  • 7/31/2019 lab inv (2)

    23/90

    Normal values Hb, g/dl

    Children (upto 1 yr) 11.0 13.0

    Children (10 -12 yrs) 11.5 14.5 Men 13 18

    Women 12 16

  • 7/31/2019 lab inv (2)

    24/90

    Clinical Significance

    A decrease in Hb is an indication of anemia

    Definition : reduction below the normal in the volume

    of packed red cells as measured by hematocrit or

    decrease in hemoglobin concentration of blood

  • 7/31/2019 lab inv (2)

    25/90

    Classification

    Most common and simple classification which isbased on the morphologic characteristics of cells

    is:

    Based on size of cells: 1. Normocytic

    2. Microcytic

    3. Macrocytic

    Based on

    hemoglobinisation of cells: 1. Normochromic

    2. Hypochromic

  • 7/31/2019 lab inv (2)

    26/90

    Microcytic/hypochromic anemia (decreasedMCV, decreased MCHC)

    Iron deficiency (common) Thalassemia (common, except in people of

    Germanic, Slavonic, Baltic, Native American, HanChinese, Japanese descent)

    Anemia of chronic disease (uncommonlymicrocytic)

    Sideroblastic anemia (uncommon; acquired forms

    more often macrocytic) Lead poisoning (uncommon)

    Hemoglobin E trait or disease (common in Thai,Khmer, Burmese,Malay, Vietnamese, and Bengali

    groups

  • 7/31/2019 lab inv (2)

    27/90

    Macrocytic/normochromic anemia(increased MCV, normal MCHC)

    Folate deficiency (common)

    B12 deficiency (common)

    Myelodysplastic syndromes (not uncommon,especially in older individuals)

    Hypothyroidism (rare)

  • 7/31/2019 lab inv (2)

    28/90

    Normochromic/normocytic anemia (normalMCV, normal MCHC)

    Normoregenerative normocytic anemias(appropriate reticulocyte response)

    Immunohemolytic anemia

    Glucose-6-phosphate dehydrogenase (G6PD)

    deficiency (common) Hemoglobin S or C

    Hereditary spherocytosis

    Microangiopathic hemolytic anemia

    Paroxysmal hemoglobinuria

  • 7/31/2019 lab inv (2)

    29/90

    Hyporegenerative normocytic anemias(inadequate reticulocyte response)

    Anemia of chronic disease

    Anemia of chronic renal failure

    Aplastic anemia*

  • 7/31/2019 lab inv (2)

    30/90

    Drugs and other substances that have

    caused aplastic anemia include the

    following:

  • 7/31/2019 lab inv (2)

    31/90

    Hemoglobin concentration drops in pregnancy due tohemodilution

    Increase in Hb concentration occurs inHemoconcentration (reduced plasma volume) due toloss of body fluid in severe diarrhea and vomiting,prolong deprivation of water, excessive use of diuretics

    High values are also observed in congenital heartdisease due to decreased O2 supply and also inpolycythemia,.

  • 7/31/2019 lab inv (2)

    32/90

    Total Erythrocyte Count

    Principle:The blood is diluted as 1: 200 with the RBC diluting fluid and

    cells are counted under high power objective by using Neubauer

    counting chamber.

    Sodium chloride 0.5 gm

    Sodium sulphate 2.5 gm

    Murcuric chloride 0.25 gm

    Distilled water 100 ml

  • 7/31/2019 lab inv (2)

    33/90

    Normal values:

    Men 4.5 6 x 106

    cells/ cu mmWomen 4 4.5 x 106cells/ cu mm

  • 7/31/2019 lab inv (2)

    34/90

    Clinical Significance:

    At birth, the total RBC count varies from 6.5 7.25million/ cu mm.

    There is a steady decline after a few hours and atthe end of 15 days to 1 month there is a slow rise tonormal adult levels.

  • 7/31/2019 lab inv (2)

    35/90

    Increase in RBC count isobserved in conditions like

    Hemoconcentration due toburns,

    Cholera, Central cyanotic condition, Emphysema, Pulmonary fibrosis, Cor pulmonale, Living at high altitude, Certain erythropoietin secreting

    tumors i.e. Renal cellcarcinoma and hepatocellularcarcinoma

  • 7/31/2019 lab inv (2)

    36/90

    Decrease in RBC count is

    seen in conditions like

    Old age, Pregnancy,

    Anemic state, Leukemias, Bbone marrow

    suppression,

    Hemorrhage.

  • 7/31/2019 lab inv (2)

    37/90

    Total Leukocyte Count

    Principle: The blood specimen is diluted as 1:20

    in a WBC pipette with the diluting fluid (Turks

    fluid) and the cells are counted under low power

    by using Neubauer counting chamber.

    Turks fluid:

    Glacial acetic aciddestroys RBCs

    1% Gention violetstains WBCs

    Distilled water

  • 7/31/2019 lab inv (2)

    38/90

    Normal values:

    At birth: 10000 25000 cells/ cu mm1-3 yrs: 6000 18000 cells/ cu mm

    4-7 yrs: 6000 15000 cells/ cu mm

    8-12 yrs: 4500 13500 cells/ cu mmAdults: 4000 11000 cells/ cu mm

  • 7/31/2019 lab inv (2)

    39/90

    Clinical Significance

    Increase in total WBC count of more than 11000 / cu

    mm is called leukocytosis and decrease of lessthan 4000 / cu mm is called leukopenia.

  • 7/31/2019 lab inv (2)

    40/90

    Causes of leukocytosis:

    Pathological: Common for a transient period in infections, certain tumors,

    myloproliferative disorders, endotoxemias, hypoxia

    Also observed severe hemorrhage and leukaemia

    Physiological:

    High temperature, muscular exercise

    At birth total leukocyte count is about 18000 / cu mm At full

    term of pregnancy total count is about 12000

    15000 / cu

    mm.

  • 7/31/2019 lab inv (2)

    41/90

    Causes of leukopenia:

    Certain viral infections like Hepatitis, HIV.

    Bone marrow depression

    Anemia

    Following treatment with: Glucocorticoids,cytotoxic drugs

    Autoimmune disorders and malnutrition

  • 7/31/2019 lab inv (2)

    42/90

    Principle: The polychromic stainingsolutions like Leishmans contain methyleneblue and eosin. These basic and acidic dyes

    induce multiple colors. The cytoplasm of WBCsis stained by acidic dye and the nucleus isstained by the basic dye. The neutral component

    of the cells are stained by both the dyes.

    Differential Leukocyte Count

  • 7/31/2019 lab inv (2)

    43/90

    Normal values

    Neutrophils : 40 - 75 %Eosinophils : 1 4 %

    Basophils : 0 1 %Lymphocytes : 20 45 %Monocytes : 2 - 8 %

  • 7/31/2019 lab inv (2)

    44/90

    Clinical Significance

    Differential count is useful to identifychanges in the distribution of white cells

    and also to determine the severity of a

    disease and the degree of response ofthe body.

  • 7/31/2019 lab inv (2)

    45/90

    Neutrophilic

    leukocytosis

    Acute bact. Infections, tissue

    necrosis caused by MI & burns

    Eosinophlia Allergic conditions: asthama, hay

    fever, pemphigus v.,malignancies

    like hodgkins and non-hodgkins

    lymphomas.

    Monocytosis TB, bact.endocarditis, malaria,SLE.

    Basophilia Rare often its an indicator of

    myloproliferative disorder like

    CML.

    Lymphocytosis TB, Brucellosis, infection caused

    by hepatitis A, CMV, EBV,

    Thyrotoxicosis.

    i i i f i

  • 7/31/2019 lab inv (2)

    46/90

    Neutropenia Starvation, infections

    and toxemias in elderly,

    typhoid,malaria,hepatiti

    s,hypersplenism,bonemarrow suppression.

    Eosinopenia Typhoid, aplasticanemia, pt. on steroids

    Lymphopenia Severe bone marrow

    supression,immunosupressivetherapy, hodgkins

    disease, irradiation.

    Monocytopenia Aplastic anemia.

    BLOOD GROUPING

  • 7/31/2019 lab inv (2)

    47/90

    BLOOD GROUPING

    Around 30 different common antigens and hundreds of rare ones

    21 different systems. Common ones are:

    ABO System

    Rh system

    Lewis system

    MNS system

    P system

    Kell system

    Duffie system

    Lutheran system

    ABO system & Rh system

    Karl Landsteiner

    1900 & 1940 47

  • 7/31/2019 lab inv (2)

    48/90

    48

  • 7/31/2019 lab inv (2)

    49/90

    Demographics

    BLOOD TYPE population %

    O 40 - 65%

    A 35 - 45%

    B 5 - 10%

    AB 3 - 9%

    49

    D t rmin ti n f H m t rit

  • 7/31/2019 lab inv (2)

    50/90

    Determination of Hematocrit

    (PCV)

    PCV is the amount of packed red blood cells

    following centrifugation and expressed aspercentage of the total blood volume.

    OR

    Percentage of volume occupied by red bloodcells in relation to total volume of blood in

    centrifuged capillary tube.

  • 7/31/2019 lab inv (2)

    51/90

    Principle of Macro Haematocrit method:

    when an anticoagulated blood is centrifuged in a

    haematocrit tube at high speed, the erythrocytes sediment

    at the bottom.

    The red cell column is called PCV or haematocrit

  • 7/31/2019 lab inv (2)

    52/90

    Principle of Micro Hematocrit method:

    Blood is centrifuged in a sealed capillary tube and PCV

    is determined by a special hematocrit reader.

    Used : 1. Pediatric patients

    2. difficulty in drawing

    Sufficient amount of

    blood

  • 7/31/2019 lab inv (2)

    53/90

    Normal values

    Birth 5056 %

    1-2 years 3238 %

    812 years 3642 %Males 4252 %

    Females 3648 %

    pregnancy 2337 %

  • 7/31/2019 lab inv (2)

    54/90

    Clinical Significance

    Decrease in hematocritvalues are observed in

    anemias, hydremia

    (excessive fluids in theblood) as occurs inpregnancy.

    Increase in hematocritvalues are observed in

    polycythemia, dehydration,

    emphysema, congenital

  • 7/31/2019 lab inv (2)

    55/90

    Color and opacity of plasma

    Yellow - Jaundice

    Milky - Lipemia

    Cloudy - Multiple myloma

    Reddish - Hemolysis

    Determination of RBC indices

  • 7/31/2019 lab inv (2)

    56/90

    Determination of RBC indices

    (wintrobes constant)

    The main indices calculated are

    Mean corpuscular volume (MCV)

    Mean corpuscular hemoglobin (MCH)

    Mean corpuscular hemoglobinconcentration (MCHC)

    Color index (CI)

    l l ( )

  • 7/31/2019 lab inv (2)

    57/90

    Mean corpuscular volume (MCV)

    Average volume of a single red blood cell and itis expressed in cubic microns i.e.(femtoliters)

    MCV = PCV x 10

    Rbcs/Cubic mm

    The normal MCV is 90 cum (78 to 90 cum).When MCV is increased, the cell is known asmacrocyte and microcyte means the cell withreduced volume.

  • 7/31/2019 lab inv (2)

    58/90

    Increased : Macrocytic Anemia

    Decreased : Microcytic Anemia

  • 7/31/2019 lab inv (2)

    59/90

    Mean corpuscular Hemoglobin

    (MCH) This is the quantity or amount or content of

    hemoglobin present in one red blood cell.

    MCH = Hb x 10Rbcs in millions/cu mm.

    Expressed in microgram or picogram (pg)

    Normol value 30 pg (27-32 pg)

  • 7/31/2019 lab inv (2)

    60/90

    Increases:

    Macrocytic anemia (may also remain normal)

    Decreases :

    Hypochromic anaemia

    M l H l bi

  • 7/31/2019 lab inv (2)

    61/90

    Mean corpuscular Hemoglobin

    concentration (MCHC)

    Portion of average red blood cell containinghemoglobin

    Amount Of Hemoglobin Expressible In Relation To TheVolume Of One Red Blood cell.

    MCHC = Hb x 100

    PCV

  • 7/31/2019 lab inv (2)

    62/90

    Most absolute important value in the diagnosis ofanemia.

    Normal value 30% (28-38%)

    Decreased :Hypochromic anemia particularly in

    microcytic hypochromic anemia

    Increased: Hereditary spherocytosis

    C l i d

  • 7/31/2019 lab inv (2)

    63/90

    Color index

    It is an expression of the mean Hb content of asingle cell in comparison to that of an arbitrarynormal cell

    Color index = Hb%

    Rbc%

    Normal is 1 (0.85 -1.2%)

  • 7/31/2019 lab inv (2)

    64/90

    Important in determining the type of anemia

    Increased: Pernicious anemia

    Megaloblostic anemia

    Reduced: Iron deficiency anemia( microcytic &

    hypochromic anemia)

    Normal: Normocytic normochromic anemia

    E th t S di t ti R t

  • 7/31/2019 lab inv (2)

    65/90

    Erythrocyte Sedimentation Rate

    The rate at which the red blood cells sediment tothe bottom of the test tube is known asErythrocyte sedimentation rate.

    Buffy layer

  • 7/31/2019 lab inv (2)

    66/90

    Normal values (Westergrens method)

    Male 515 mm after 1 hour

    Female 520 mm after 1 hour

    Normal values (Wintrobe method)

    Male 0

    9 mm after 1 hourFemale 020 mm after 1 hour

    Normal values (Landau method)

    Male 05 mm after 1 hourFemale 08 mm after 1 hour

  • 7/31/2019 lab inv (2)

    67/90

    E.S.R. determination is useful to determine

    the progress of the disease and not specific

    for diagnosis of a perticular disease except in

    rheumatic fever (minor criteria).

    Clinical Significance

  • 7/31/2019 lab inv (2)

    68/90

    g

    ESR is increased in any condition causing an increasein fibrinogen or globulins like rheumatic fever, multiple

    myeloma, kala azar, anemias, high temperature,

    malignancies.

    ESR is greater in women than in men

    During pregnancy ESR gradually increases after 3rd

    month and returns to normal in about 3-4 weeks after

    deliveryLow blood count tend to accelerate ESR

    Drugs : Theophylline, vitamin A, Oral contraceptives

  • 7/31/2019 lab inv (2)

    69/90

    ESR is decreased in polycythemia, sickle cell anemia,

    hypochromic anemia, severe dehydration, gastritis,

    c.c.f. and in infants.

    Clinical Significance

    D t i ti f Pl t l t

  • 7/31/2019 lab inv (2)

    70/90

    Determination of Platelet

    Count

    Principle: The blood is diluted to as 1:200 with thediluting fluid using the RBC pipette. After discardingthe first drop, the specimen is transferred to the

    counting chamber. Placing the counting chamberunder the petri dish with a moist filter paper allowsthe platelets to settle and also prevents theevaporation of diluting fluid. When observed

    through the microscope, platelets will appear likehighly refractile particles.

    Normal Range: 250000 500000 /cu mm

  • 7/31/2019 lab inv (2)

    71/90

    Normal Range: 250000 500000 /cu mm

    Clinical Significance :

    Determination of platelets is done in cases of

    suspected bleeding disorders.

    Clinical Significance

  • 7/31/2019 lab inv (2)

    72/90

    g

    Thrombocytosis is found in polycythemia vera,following splenectomy and Acute rheumatic fever,Hemolytic anemias

    Thrombocytopenia is associated with prolonged

    BT and poor clot retraction and also occurs in

    aplastic anemia, megaloblastic anemia,

    hypersplenism, acute and chronic leukemias, sub

    acute bacterial endocarditis etc.

    Determination of Reticulocyte

  • 7/31/2019 lab inv (2)

    73/90

    y

    Count

    Principle of Supravital staining method: Blood ismixed with the stain which enters the cells and theRNA of the cells is precipitated by staining as dark

    blue network or reticulum.

    Reticulocyte % = No. of reticulocytes counted X 100

    No . of red cells counted

  • 7/31/2019 lab inv (2)

    74/90

    Normal Range: Adults 0.2 2 %Infants 2 6 %

  • 7/31/2019 lab inv (2)

    75/90

    Clinical Significance: The number of reticulocytes

    in peripheral blood is a reflection of red cellforming activity (erythropoietic activity) of bonemarrow.

    Increase in their number indicates hyper activity of

    marrow called reticulocytosis seen in acuteblood loss or hemolytic anemia.

    Low counts of reticulocytes indicates bone marrowdepression seen in aplastic anemia.

    Determination of Absolute

  • 7/31/2019 lab inv (2)

    76/90

    Eosinophil Count

    Principle :Blood is diluted with a special diluting fluid( Hingleman solution) that removes the red cells and

    stains the eosinophils red. These cells are then

    counted using Neubauer counting chamber.

    Normal Range: 40 440 / cu mm

  • 7/31/2019 lab inv (2)

    77/90

    Clinical Significance:

    Increase eosinophil count is associated withallergic reactions, parasitic infections,brucellosis, leukemias etc.

    Decrease in eosinophil count suggest hyperadrenalism or Cushings syndrome

    Bleeding Time

  • 7/31/2019 lab inv (2)

    78/90

    Bleeding Time

    Normal range: Dukes method: 1 5 minutes

    Ivy method: 5 - 11 minutes

    Prolonged bleeding time is observed inThrombocytopenia, Platelet function disorders,Vascular abnormalities, Anti-platelet

    medication(Aspirin), Von-willebrands disease,Leukemia, Aplastic anemia

    Clotting Time

  • 7/31/2019 lab inv (2)

    79/90

    Clotting Time

    Normal range: Lee and White method: 5 - 10 minutes

    Capillary method: 1 7 minutes

    Clinical significance

  • 7/31/2019 lab inv (2)

    80/90

    Clinical significance

    Clotting time is prolonged in case of coagulationdisorders like hemophilia,von willebrandsdisease,afibrinogenemia.

    Prothrombin time

  • 7/31/2019 lab inv (2)

    81/90

    Prothrombin time

    (Quick,s method)

    The time required for coagulation of citratedplasma after addition of thromboplastin,calcium mixture.

    Now it is commonly reported with INR.Ratio of prothrombin time that adjusts for thesensitivity of thromboplastin reagent such thatcoagulation profile is reported as INR of 1.

    Normal 10-15 sec

    I d

  • 7/31/2019 lab inv (2)

    82/90

    Increased

    Anti Coagalant therapy like heparin

    Obstructive jaundice

    Cirrhosis of liver

    Malignancy of liver

    Post partum hypofibrinogenemia Congenital deficiency of I, II, V, VII, & IX

    Malabsorption syndrome

    Early Vit k def

    Warfarin therapy

  • 7/31/2019 lab inv (2)

    83/90

    If P.T. is prolonged - thrombin clotting time isrecommended.

    Prolonged PT & PTT defects in commonpathway, ie both intrinsic and extrinsic

    Prolonged PT but not PTT (PartialThromboplastin Time), defect in extrinsicpathway.

    Partial thromboplastin time:

  • 7/31/2019 lab inv (2)

    84/90

    Partial thromboplastin time:

    Partial thromboplastin ( Rabbits brain aschloroform extact) is mixed with test plasma andCa++ ions, clot formation takes place.

    Normal range: 15- 35 secs.

    Cli i l i ifi

  • 7/31/2019 lab inv (2)

    85/90

    Clinical significance

    PTT is a sensitive measure for the factorsrequired in intrinsic pathway. This is

    increased in deficiency of factor I, II, V, VIII, IX,X, XI, XII also in SLE.

    A ti t d ti l th b l ti ti

  • 7/31/2019 lab inv (2)

    86/90

    Activated partial thromboplastin time

    Principle:partial thromboplastin ( brain extract in

    chloroform ) is incubated with kaolin

    (factor XII, contact factor activator.) the clottingtime of plasma is determined after

    the addition of Ca++ ions

    Normal range: 35-40 sec

    Cli i l Si ifi

  • 7/31/2019 lab inv (2)

    87/90

    Clinical Significance:

    Prolonged in1. haemophilia

    2. vit. K deficiency

    3. liver diseases

    4. presence circulating anticoagulant

    5. D.I.C.

    Shortened in

    1. malignancies except those of liver

    2. immidiately after acute hemorrhage

    PLASMA THROMBIN TIME

  • 7/31/2019 lab inv (2)

    88/90

    PLASMA THROMBIN TIME

    This is the time taken for plasma to clot whencommercially available thrombin is added.

    Measure of fibrinogen level. Also affected by excess

    of heparin and other anticoagulants.

    Normal range: 15 20 secs

    Cli i l i ifi

  • 7/31/2019 lab inv (2)

    89/90

    Clinical significance

    Prolonged

    Afibrinogenemia

    Chronic liver diseases

    Heparin administration

    Multiple myeloma.

    E d f t I

  • 7/31/2019 lab inv (2)

    90/90

    End of part I

    MILES TO GO